# A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)

> **NCT01446003** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 31 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK-8457
- **DRUG:** Placebo for MK-8457

## Key facts

- **NCT ID:** NCT01446003
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-25
- **Primary completion:** 2012-02-18
- **Final completion:** 2012-03-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446003, "A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01446003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*